FARXIGA 5 MG TABLET

DAPAGLIFLOZIN
$12.0700per EA

Strength

5 mg/1

NDC

00310620530

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

DAPAGLIFLOZIN PROPANEDIOL

Approval Type

New Drug (NDA)

FDA Application

NDA202293

On Market Since

1/14/2008

Pharmacological Classes

Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-37.0%

1Y

-37.1%

3Y

-33.3%

5Y

-29.2%

All

+19.6%